ADNI: Alzheimer's Disease Neuroimaging Initiative
Alzheimer's Disease Neuroimaging Initiative
Sponsor: Alzheimer's Association
This observational or N/A phase trial investigates Alzheimer's Disease and is currently completed. Alzheimer's Association leads this study, which shows 13 recorded versions since 2005 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
13 versions recorded-
Jan 2026 — Present [monthly]
Completed
-
Sep 2025 — Present [monthly]
Completed
-
Sep 2024 — Sep 2025 [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Dec 2021 — Jul 2024 [monthly]
Completed
▶ Show 8 earlier versions
-
Jan 2021 — Dec 2021 [monthly]
Completed
-
Nov 2020 — Jan 2021 [monthly]
Completed
-
Sep 2020 — Nov 2020 [monthly]
Completed
-
Jun 2018 — Sep 2020 [monthly]
Completed
-
May 2018 — Jun 2018 [monthly]
Completed
-
Apr 2018 — May 2018 [monthly]
Completed
Phase: NA → None
-
Aug 2017 — Apr 2018 [monthly]
Completed NA
-
Jan 2017 — Aug 2017 [monthly]
Completed NA
First recorded
Jul 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Alzheimer's Association
- Alzheimer's Disease Cooperative Study (ADCS)
- Alzheimer's Drug Discovery Foundation
- Foundation for the National Institutes of Health
- National Institute for Biomedical Imaging and Bioengineering (NIBIB)
- National Institute on Aging (NIA)
- Northern California Institute of Research and Education
For direct contact, visit the study record on ClinicalTrials.gov .